Literature DB >> 16210627

KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand.

William Henry Carr1, Marcelo Jorge Pando, Peter Parham.   

Abstract

The killer cell Ig-like receptor (KIR) gene family encodes MHC class I receptors expressed by NK cells and several T cell subpopulations. Factors contributing to human KIR haplotype diversity are differences in gene number, gene content, and allelic polymorphism. Whereas functional and clinical consequences of the first two factors are established, knowledge of the effects of KIR gene polymorphism is limited to special cases in which signaling function is reversed or cell surface expression lost. In this study we use retrovirally transduced human cell lines to show that 3DL1*002 is a stronger inhibitory receptor for HLA-Bw4 ligands than 3DL1*007. Analysis of mutant 3DL1*002 and 3DL1*007 molecules demonstrates that residue 238 in the D2 domain and 320 in the transmembrane region contribute to the difference in receptor strength. Neither position 238 nor 320 is predicted to interact directly with HLA-Bw4 ligand. This study also revealed that KIR3DL1 and LILRB1 both contribute to developing an inhibitory response to HLA-Bw4 ligands.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210627     DOI: 10.4049/jimmunol.175.8.5222

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  89 in total

1.  Differential RNA expression of KIR alleles.

Authors:  Colum McErlean; Asensio A Gonzalez; Rodat Cunningham; Ashley Meenagh; Tanya Shovlin; Derek Middleton
Journal:  Immunogenetics       Date:  2010-05-08       Impact factor: 2.846

2.  Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation.

Authors:  William H Carr; David B Rosen; Hisashi Arase; Douglas F Nixon; Jakob Michaelsson; Lewis L Lanier
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

3.  Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?

Authors:  Rasmi Thomas; Eriko Yamada; Galit Alter; Maureen P Martin; Arman A Bashirova; Paul J Norman; Marcus Altfeld; Peter Parham; Stephen K Anderson; Daniel W McVicar; Mary Carrington
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

Review 4.  KIR and HLA under pressure: evidences of coevolution across worldwide populations.

Authors:  Danillo G Augusto; Maria Luiza Petzl-Erler
Journal:  Hum Genet       Date:  2015-06-23       Impact factor: 4.132

5.  CD8αα homodimers function as a coreceptor for KIR3DL1.

Authors:  Jie Geng; Malini Raghavan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-16       Impact factor: 11.205

6.  Improved full-length killer cell immunoglobulin-like receptor transcript discovery in Mauritian cynomolgus macaques.

Authors:  Trent M Prall; Michael E Graham; Julie A Karl; Roger W Wiseman; Adam J Ericsen; Muthuswamy Raveendran; R Alan Harris; Donna M Muzny; Richard A Gibbs; Jeffrey Rogers; David H O'Connor
Journal:  Immunogenetics       Date:  2017-03-25       Impact factor: 2.846

Review 7.  Co-evolution of MHC class I and variable NK cell receptors in placental mammals.

Authors:  Lisbeth A Guethlein; Paul J Norman; Hugo G Hilton; Peter Parham
Journal:  Immunol Rev       Date:  2015-09       Impact factor: 12.988

8.  HLA alleles determine differences in human natural killer cell responsiveness and potency.

Authors:  Sungjin Kim; John B Sunwoo; Liping Yang; Taewoong Choi; Yun-Jeong Song; Anthony R French; Anna Vlahiotis; Jay F Piccirillo; Marina Cella; Marco Colonna; Thalachallour Mohanakumar; Katharine C Hsu; Bo Dupont; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

9.  Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

Authors:  Maureen P Martin; Ying Qi; Xiaojiang Gao; Eriko Yamada; Jeffrey N Martin; Florencia Pereyra; Sara Colombo; Elizabeth E Brown; W Lesley Shupert; John Phair; James J Goedert; Susan Buchbinder; Gregory D Kirk; Amalio Telenti; Mark Connors; Stephen J O'Brien; Bruce D Walker; Peter Parham; Steven G Deeks; Daniel W McVicar; Mary Carrington
Journal:  Nat Genet       Date:  2007-05-13       Impact factor: 38.330

10.  KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C.

Authors:  Thorsten Graef; Achim K Moesta; Paul J Norman; Laurent Abi-Rached; Luca Vago; Anastazia M Older Aguilar; Michael Gleimer; John A Hammond; Lisbeth A Guethlein; David A Bushnell; Philip J Robinson; Peter Parham
Journal:  J Exp Med       Date:  2009-10-26       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.